Triple blood pressure pill after a brain bleed
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a combination of three blood pressure medicines can better control blood pressure after a brain bleed (intracerebral hemorrhage). It may help prevent another bleed or stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a spontaneous brain bleed (not caused by injury).
- You are 18 years or older.
- Before the bleed, you could walk and care for yourself with some help (score 0–3 on a scale).
- Your risk of poor outcome (TRICH score) is 3 or higher.
- You started this trial within 1 week of your brain bleed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a mobile health app (WeRISE) to help people who survived an intracerebral hemorrhage (a type of brain bleed) monitor health and manage blood pressure after discharge. It may help you reduce the risk of problems related to high or unstable blood pressure.
This Phase 3 study tests whether a blood thinner (apixaban) can help prevent another stroke and support recovery after you’ve had a brain bleed. You would be assigned to a treatment group, and the study checks safety and whether strokes can be reduced without causing dangerous bleeding.
This trial tests a blood pressure medicine called clevidipine given through an IV to people with a brain bleed (intracerebral hemorrhage). The goal is to see if quickly lowering blood pressure helps prevent more bleeding and improve recovery.
This study tests whether giving a combination of blood-pressure-lowering medicines early after a brain bleed can reduce swelling and improve recovery. It aims to start treatment within 3 days of the bleed to see if it helps limit brain damage.
This study tests two sedative medications, remifentanil and dexmedetomidine, to lower blood pressure quickly after a brain bleed (intracerebral hemorrhage). High blood pressure right after a bleed can cause more damage, so this trial aims to see if these drugs help improve recovery.
This trial tests whether a common antiplatelet medicine can reduce the risk of future heart attacks, strokes, or blood clots in people who have had a brain bleed. It's for adults who had their first brain bleed and can start treatment within 3 months of the stroke.
Hear when a new Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.